Visit our allergy section for the latest news on this subject.
ARTICLE:
DM Fleischer et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. Journal of Allergy and Clinical Immunology DOI: 10.1016/j.jaci.2012.11.011 (2013).
Marshall Plaut, M.D., chief, Food Allergy, Atopic Dermatitis, and Allergic Mechanisms Section, NIAID's Division of Allergy, Immunology, and Transplantation, is available to discuss this study.
RESOURCE INFORMATION:
This work was funded by NIAID, NIH, under grant numbers U19AI066738 and U01AI066560, and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH, under grant numbers UL1RR025780, UL1TR000067, UL1TR000039, UL1RR024128, and UL1RR025005. The ClinicalTrials.gov identifier for the study A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial is NCT00580606.
MLA
n.p. "In Clinical Study, Peanut Therapy Shows Promise In Treating Peanut Allergy." Medical News Today. MediLexicon, Intl., 9 Jan. 2013. Web.
27 Jan. 2013. <http://www.medicalnewstoday.com/releases/254670.php>
APA
http://www.medicalnewstoday.com/releases/254670.php.
Please note: If no author information is provided, the source is cited instead.
No comments:
Post a Comment